EGFR and lung cancer: In summary, our data identified a crucial oncogenic role of Mig-6 in the survival of EGFR-TKI-resistant lung adenocarcinoma and we suggest targeting Mig-6 to overcome EGFR-TKI resistance in lung cancer (Fig. 7).